chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stinging rash on back of both legs and forearms; Hives on back of armpits.; Uncomfortable and itchy; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 02Apr2021 at 14:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced itch, stinging rash on back of both legs and forearms. The patient also experienced hives on back of armpits. Uncomfortable and itchy. This hives turned into what looked like chicken pox. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of itchy, stinging rash and hives and included treatment with topical steroid. The clinical outcome of the events itchy, stinging rash on back of both legs and forearms (painful rash) and hives on back of armpits were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Child came in on 11/22/04 with rash and fever. Mom stated "started 3 days ago", rash? Roseola or Rubella 2 to MMR, Fever 102 x2 days, decreased fever and rash.
30 minutes after leaving our office after receiving immunizations at his well child check, patient returned with mother. At the time of return he was flushed with hives present; eyelids, tongue, and lips swollen; pt was having difficulty swallowing; decreased responsiveness (eyes open but not talking).  911 called. Tachycardic on exam by Dr.  Respiratory rate normal. Epi-pen Jr administered to left thigh. Oxygen saturation was 96-98%.  Paramedics arrived with in 5 minutes and patient was transported to hospital in stable condition for further evaluation and treatment.
On 12/26 I began itching in my scalp, uncontrollably. Once I became aware of how frequently I was itching when I went to sleep that night, I tried stopping itching. Then I became itchy on other parts of my body (legs, arms, lower abdomen, lower back). I woke up in the morning and tried showering, which did not help. I tried hydrocortisone cream, which helped only temporarily. I had to reapply throughout the day to keep the itching at bay. I took Benadryl before bed on the 27th. The next morning, (12/28) I noticed a tightness in my chest and later that day, a feeling as though the side of my mouth was tingling/going numb, which went away after a little bit. I went to a walk-in clinic later that night and was prescribed a 6 day course of prednisone, tapered (3 pills for 2 days, 2 for 2 days and 1 for 2 days). I saw no changes in the hives that were breaking out on my body, but I did experience less itching. On Monday 1/3, I saw a doctor who prescribed me another course of prednisone (a higher dose than the first time), and then again 5 days later when my condition had gotten a little bit better but not gone away completely. I stopped taking prednisone on 1/14/22 and  my hives have not gone away. The itchiness comes and goes now but I am taking Xyzal every day and Hydroxyzine every night for as long as I have pills.
sore arms; This is a spontaneous report from a contactable Other HCP. This 35-year-old female Other HCP (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 for covid-19 immunization. Medial history and concomitant drug were not reported. Patient experienced sore arms, no other symptoms after received 1st dose. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient received her vaccine then sat in a chair while her 14 year old brother got his second chicken pox shot, she was laughing and goofing around with her 12 year old brother. Then within minutes she was on the floor, her body started shaking and she started making noises.  The nurse stated that this never happened before and ran out of the room to get Dr.  After he was in the room a short time patient came to and he helped her back into the chair.  He tried telling me that it was probably 'cause her blood sugar was low from not eating, not true she ate two hours before she got her vaccine.  She was pale, confussed and talking slowly.  Dr.  then gave her some water and put an ice pack on the back of her neck, told me she'd be fine.  For the next three hours at home patient was hoarse, had slurred speech and responded to everything very slowly.  Her face ended up swollening as did her eyes, her face and eyes are still somewhat swollen today.  She hurt her right thumb when she fell, Dr. said it is probably sprained, but never took an x-ray.  We  went back to see Dr. yesterday, patient still swollen and slow.  She stated that maybe Patient just fainted because of being worked up about getting a shot but she has no idea why her speech would be slurred or why she would be hoars.  I tried to explain to her that patient was not worked up about the shot and her and her brother were goofing around when patient ended up on the floor but she wouldn't listen.  She said that when people have a siezure they will pee and poop their pants, however I have friends that have siezures and they never have done that. The paper I received after patient's reaction states that a reaction can happen within minutes to a few hours of the vaccine and the doctor keeps telling me it can't happen that fast. Patient is still swollen this morning,she just got up so I am not sure how her reactions are.  Patient gets almost all staight A+'s in school I am worried how this will effect her.
CHEST PAIN, ANXIETY, COLD THROAT AND EARS, LEFT FEELING FINE.
7/21/19 onset headache 7/22/19 severe headache, fever 103 degrees F, shaking, joint aches 7/23/19 worsened joint aches, swollen glands 7/24/19 headache, low fever, joint aches 7/25/19 feeling better, but states "joints still feel loose", but not aching
Course of illness prior to death unknown.  Aware she did have URI and could not attend school.  1/27/09 Autopsy report states COD as acute bronchopneumonia due to acute intoxication by hydrocodone.  Also states additional anatomic dx: mod hepatocellular fatty metamorphosis & early postmortem decomposition.  11/11/08 Reviewed PCP medical records of 10/27/2008. FINAL DX:COPD, cough, acute rhinitis, chronic sinusitis Records reveal patient experienced cough & body pain, no fever.  Dx w/COPD & acute bronchitis.  Tx w/antibiotics & cough med.
No event described. From the notes can only tell that the number of events had increased after vaccinations had been given.
felt "achy"; This is a spontaneous report from a non-contactable consumer. A elderly male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the COVID-19 shot and he felt "achy" on unspecified date. It was unknown if treatment was received. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. It was unknown if the patient has been tested for COVID-19. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
This case was reported by a physician and described the occurrence of erythema multiforme in a 3-month-old male subject who was vaccinated with Pediarix, (GlaxoSmithKline), Prevnar, (Wyeth Labs) and Hib, (manufacturer unknown) for prophylaxis. On an unspecified date the subject received 1st doses of Pediarix (0.5 ml), Prevnar and Hib. At an unspecified time after vaccination with Hib, Pediarix and Prevnar, the subject experienced rash, lesion, irritability and diarrhea. He was later diagnosed with erythema multiforme. This case was assessed as medically serious. At the time of reporting the outcome of the events was unspecified. The physician considered the events were probably related to vaccination with Pediarix, Prevnar and Hib.
Headache; Tiredness; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 38-years-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0167), via an intramuscular route of administration (at the age of 38-years), administered in arm right on 28Apr2021 19:20  as dose 2, single for COVID-19 immunization. The patient medical history included family history as Mother and Maternal Mother with Diabetes type 2 and none from an unknown date and unknown if ongoing. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8731), via an intramuscular route of administration (at the age of 38-years), administered in arm right on 07Apr2021 20:00 as dose 1, single for COVID-19 immunization and experienced headache and tiredness. The concomitant medications were not reported. On an unspecified date in 2021, the patient experienced headache and tiredness. Patient stated that it felt more intense in the second dose in both I felt both I felt good after the second day of the vaccination. The treatment was not received for the event. The clinical outcome of the event was reported as recovered on an unspecified date in 2021.
Hurt a little bit after the 1st dose. Doubting if she had been vaccinated correctly.; This is a spontaneous report from a contactable consumer (patient).   A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, solution for injection) via an unspecified route of administration on 04Feb2021 at single dose for COVID-19 immunisation.  The patient medical history was not reported and concomitant medications were not reported.  The patient experienced hurt a little bit after the 1st dose. doubting if she had been vaccinated correctly on an unspecified date. The caller mentioned that she received the first dose of the vaccine last thursday and was concerned because she did not feel anything and that the injection was too fast and did not hurt. She was expecting to have side effects because her son and granddaughters experienced chills and fevers after their shots. She was observing herself last friday and today and observed nothing but a little hurt in Feb 2021. She mentioned that the injection only slightly touched her skin and she didn't feel anything. She is worried and nervous because she doubts that she was properly vaccinated. She was scheduled to have her second dose on 25Feb2021.The outcome of event was unknown. Information on Lot/Batch has been requested.
More than 30 days after receiving the Janssen vaccine, I tested positive for COVID-19.  Symptoms began as runny nose, sneezing, and sinus pressure/burning on April 6, 2021.  Tested for COVID-19 on April 11, 2021 (nasal swab, PCR test) after a family member tested positive.  Symptoms worsened on April 12, 2021, including shortness of breath, chest pain, complete loss of taste and smell.  Sought treatment for breathing difficulty at ER on April 13, 2021 (Vidant Medical Center and was instructed to rest at home.  Sought treatment for breathing difficulty at PCP on April 14, 2021 ( Medical Center) and prescribed Prednisone.  Symptoms worsened on April 15, 2021, including shortness of breath, chest pain, numbness in face/arms/legs, dizziness, loss of balance, memory and speaking difficulty, near fainting.  Sought treatment at ER on April 15, 2021 (Vidant Medical Center, Greenville, NC).  Held for three days, treated with Remdesivir (3 doses) and supplemental oxygen.  Discharged from hospital on April 18, 2021.  Symptoms did not improve following discharge.  Sought treatment for ongoing symptoms at ER on April 21, 2021, instructed to rest at home.  Symptoms continued to worsen on April 24, 2021, including shortness of breath, chest pain, numbness in face/arms/legs, dizziness, loss of balance, memory and speaking difficulty, near fainting, and slurred/incoherent speech.  Sought treatment at ER on April 15, 2021, admitted to hospital on April 25, 2021 diagnosed with probable TIA.  Treated with Optiflow high-flow oxygen therapy, nebulizer, and steroids.  Received a variety of tests and scans of head, neck, spine, chest, heart; none showed signs of any serious cardiac, vascular, or neurological problems.  Transferred to in-patient rehabilitation on May 1, 2021 for physical and occupational therapy.  Discharged from in-patient rehabilitation on May 6, 2021.  Prescribed out-patient physical and occupational therapy to resolve remaining dizziness, balance, and endurance deficits.
p/vax pt exp gen vesicles;1wk prior pt had c/o malaise & an ill feeling & was aching all over;9/11/98 pt was dx w/varicella rash;
Information has been received on 27-NOV-2018 from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 01-SEP-2015, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 28-NOV-2016, the patient was treated by a healthcare provider at a health clinic for shingles. The patient was diagnosed with shingles and or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (not further specified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
seven months pregnant now; arm soreness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (seven months pregnant now) and PAIN IN EXTREMITY (arm soreness) in a 31-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 11-Jan-2021 and the estimated date of delivery was 18-Oct-2021. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (seven months pregnant now). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 16-Jan-2021, PAIN IN EXTREMITY (arm soreness) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (seven months pregnant now) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to (Patient Link).; Sender's Comments: This is a case of Exposure during pregnancy with associated adverse event for this 31-year-old female patient. Patient will continue to be contacted for further monitoring of AE during the pregnancy. Considering currently available information and plausible temporal association between product use and onset of associated event, causal role cannot be excluded and thus, causality for Pain in extremity is assessed as possibly related.
Information has been received from a nurse referring to a male patient of unknown age. On 25-SEP-2015, the patient was vaccinated with one improperly stored dose of GARDASIL 9 (lot # L014415, expiration date 21-SEP-2016, dose and route unknown). No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
angina; Initial information received on 02-Nov-2020 regarding an unsolicited valid serious case received from a physician.  This case involves female patient of an unknown age who experienced angina (angina pectoris), after she received vaccine INFLUENZA VACCINE.  Past vaccination included flu vaccine (last year) had experienced chest pain and angina. It was also reported that she was admitted to the emergency room and it was determined to be not an Immunoglobulin E (IgE) reaction.  Medical history, medical treatment, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious angina (angina pectoris), (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was reported that once again the patient was admitted to the emergency room for angina.   Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was not reported.  Information on the batch number was requested.; Sender's Comments: This case involves a female patient of an unknown age who had angina pectoris, after vaccination with NFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Rec'd vaccination on Oct 21,  site swelling and pain. Then on Friday, Oct 23 awoke 7AM with nausea, heartburn, stomach ache, chills, diahreah, headache, tired & weak.  Persisted mostly thru the next day. Then on Sunday, Oct 25, just still stomach ache and headache, tired and weak.  Finally on Tuesday,  Oct 27, finally feeling 80% of normal.
minor abdominal pain that lasted about a week, It was not directly after the shot so I don't know if it was vaccine related.  I went to doctor to check it out.  no real issues with vaccine but thought I'd report MINOR abdominal pain.
PATIENT FELT ITCHING AT THE INJECTION SITE, BENADRYL 50MG IMGIVEN, TOLERATED WELL, SYMPTOMS IMPROVED,ENCOURAGED TO F/U WITH PCP
Hives over body. Benadryl pill and Benadryl cream applied daily. Helped to clear it up.
tested positive; This is a spontaneous report from a Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (BNT162B2,Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 19Feb2021 at a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested positive on 20Feb2021. The patient underwent lab tests and procedures which included the test was positive on 20Feb2021. After tested positive, the following day for his pre-surgery, the surgery was also cancelled, and was informed to wait 90 days. His second dose was scheduled on 12Mar2021. The outcome of the event was unknown.   Information about Lot/Batch number is requested.
Severe headaches (immed. after 1st course) continuing almost daily.  Joint aches, extreme malaise and lethargy.  (2 visits to eye specialist - reported to physician).  9/23/08 Reviewed PCP medical records & vaccine records.  PCP office called parent for status check as they were unaware of any problems patient had.  Office states patient had severe HA after 1st & 3rd HPV vaccines.  Parent reports patient is completely asymptomatic now.  Eye exam of 12/31/07 reveals clear vision & no pain. 1/26/2010 Headaches have lessend but still occurring.
Redness, itching, swelling at site (L) deltoid and a small knot 5-6" away from injection site; pain and fever for one week.
This spontaneous case, initially received on 21-Nov-2016, was reported by a health professional and concerns a(n) adult unk patient. Weight: not provided; Height: not provided. Concomitant medication: refer to appropriate report section. Administration of company suspect drug(s): The patient received AFLURIA from Oct-2016 to Oct-2016. Dose regimen: 0.5 ml, Site: Deltoid area, Route of administration: Intramuscular. Batch number: WT54707. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced Significant pain that lasted 2 weeks or longer at the injection site (outcome: Not recovered / Not resolved). Follow-up information received 13-Dec-2016: The patient did not receive any other concomitant vaccination on the same arm. The patient was recommended to rest arm and use ice or heat if needed for pain. The patient experienced no other associated symptoms. The outcome was reported as complete recovery. All doses were administered by a RN (registered nurse) or a Certified Medical Assistant who is also a paramedic. Both have been administering flu vaccines for years. A 22 gauge 1 inch or 1.5 inch needle was used. The RN is certain that the dose was administered correctly in the deltoid muscle of the arm as trained. Case correction 23-Feb-2017: Follow-up information received on 13-Dec-2016 missing the following information: QA investigation results (final assessment): Risk has been excluded. The review and investigation of the manufacturing, dispensing, shipping and product testing of Influenza Vaccine lot: WT54707 found no evidence of a product quality issue to prompt the potential 'vaccine reaction'.
Patient experienced rash and swelling at site of injection. Also stated very sore. Patient was told to take ADVIL if tolerated and cold compress. Also told to call if worsening symptoms.
2 hours after shot, muscle spasms started at injection site, approximately once every hour for the past 4 days - I suggested an ice pack, and MOTRIN, and call PCP.
1) COVID-Arm: Appeared Aug. 23-24. Red 2 inch diameter circle that was itchy and hot where I received the COVID shot. Was clear of color by Wednesday, Aug. 25, yet still itchy 2) Neuro: Tingling in left hand 8/19; apx. 1:25 p.m. for about 5 minutes. Tingling in right ring and pinkie fingers on 8/27 8:20 a.m. for about 5 minutes. Extra vigilant in anything out of the ordinary given Guillan Barre Syndrome history.
Developed Bell's Palsy on Saturday May 15, 2021.  Went to Hospital Emergency Room concerned that I was having a stroke.  After CT and Neurologist consult, determined the condition was Bell's Palsy.